...
首页> 外文期刊>Tissue antigens. >Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
【24h】

Unexpected Bw4 and Bw6 reactivity patterns in new alleles.

机译:新等位基因中意外的Bw4和Bw6反应性模式。

获取原文
获取原文并翻译 | 示例

摘要

The Bw4 and Bw6 epitopes were the first HLA-B differences to be recognized by serological methods. Since then 44 serological groups have been identified and more than 250 alleles assigned by molecular typing methods. In general each serological HLA-B group is associated with the presence of either the Bw4 or the Bw6 epitope. There are several exceptions to this rule. Four alleles, B*4601, *7301, *5503 and *1806, show no serological reactivity with either Bw4 or Bw6. Although the Bw6 motif at residues 77-83 is present in these alleles the Bw6 epitope is modified by a valine at residue 76. One or more alleles from the B8, B40 and B62 groups are identified as Bw4 positive, whereas all others are Bw6 positive. In the groups B27, B44 and B47 several alleles are found to be Bw6 positive, while the majority is Bw4 positive. Histocompatibility testing of dialysis patients and their families revealed the serological presence of an unexpected Bw4 epitope associated with B18 in one patient and B56 in another. Allele-specific amplification and sequencing of exons 2 and 3 of these HLA-B alleles revealed the presence of the Bw4 sequence motif for both. The new alleles were assigned B*1809 and B*5607, respectively. In 2 other patients the presence of a new B*07 allele was determined by sequence based typing. Although the new allele, B*0715, showed the Bw6 sequence motif at positions 77 to 83, a substitution of amino acid 76 from glutamic acid to valine was identified. This change resulted in an aberrant Bw6 serological reaction pattern.
机译:Bw4和Bw6表位是血清学方法识别的第一个HLA-B差异。从那时起,已经鉴定出44个血清学组,并通过分子分型方法分配了250多个等位基因。通常,每个血清学HLA-B基团与Bw4或Bw6表位的存在相关。此规则有几个例外。 B * 4601,* 7301,* 5503和* 1806这四个等位基因与Bw4或Bw6均无血清反应性。尽管这些等位基因中存在残基77-83的Bw6基序,但Bw6表位在残基76处被缬氨酸修饰。来自B8,B40和B62组的一个或多个等位基因被鉴定为Bw4阳性,而所有其他等位基因均为Bw6阳性。在B27,B44和B47组中,发现几个等位基因为Bw6阳性,而大多数为Bw4阳性。对透析患者及其家属的组织相容性测试显示,血清中存在与一名患者中的B18和另一名患者中的B56相关的意外Bw4表位。这些HLA-B等位基因的外显子2和3的等位基因特异性扩增和测序揭示了两者的Bw4序列基序的存在。新等位基因分别被指定为B * 1809和B * 5607。在其他2位患者中,通过基于序列的分型确定了新的B * 07等位基因的存在。尽管新的等位基因B * 0715在77-83位显示了Bw6序列基序,但仍鉴定出氨基酸76从谷氨酸取代为缬氨酸。这种变化导致异常的Bw6血清反应模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号